Cohesin Fusion Proteins for HIV Env Antibody Evaluation
Corresponding Organization : Institut de Recherche Vaccinale
Other organizations : Université de Bordeaux, Institut national de recherche en informatique et en automatique, Institute of Medical Microbiology and Hygiene, University of Regensburg, Duke Medical Center, National Institutes of Health, Arizona State University, Oncovir (United States), Infectious Disease Research Institute, Fred Hutch Cancer Center, University Hospital of Lausanne
Protocol cited in 1 other protocol
Variable analysis
- Env gp140 sequence
- Env fragments (gp120 residues 94–1550; gp41 residues 1551–2064)
- HIV Env-specific IgG antibody titers in serum from vaccinated animals
- Cohesin fusion proteins
- 2 μg/ml of the cohesin fusion proteins in 0.2 M sodium carbonate-bicarbonate buffer, pH 9.4
- Serial dilutions of serum starting at 1:500 in TBS blocking solution
- HRP-conjugated goat anti-human IgG in TBS blocking solution
- HRP substrate (TMB, Life Technologies)
- Not explicitly mentioned
- Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!